TickerFacts.

Nu Skin Enterprises, Inc. (NUS): Cash & Equivalents

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2009-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$238.63M
As of 2025-12-31
$189.64M
As of 2026-06-30
-3.4%
3-year compound annual growth
-9.9%
5-year compound annual growth
-1.9%
10-year compound annual growth
$525.15M2008-12-31: $229.17M2009-12-31: $158.04M2010-12-31: $230.34M2011-12-31: $272.97M2012-12-31: $320.02M2013-12-31: $525.15M2014-12-31: $288.42M2015-12-31: $289.35M2016-12-31: $357.25M2017-12-31: $426.40M2018-12-31: $386.91M2019-12-31: $335.63M2020-12-31: $402.68M2021-12-31: $339.59M2022-12-31: $264.73M2023-12-31: $256.06M2024-12-31: $186.88M2025-12-31: $238.63M$238.63M
2008-12-31 Cash & Equivalents (USD) 2025-12-31
Period endedCash & EquivalentsChange YoYSource filing
2025-12-31$238.63M+27.7%2026-02-13, Balance as of period end
2024-12-31$186.88M-27.0%2026-02-13, Balance as of period end
2023-12-31$256.06M-3.3%2025-02-14, Balance as of period end
2022-12-31$264.73M-22.0%2024-02-15, Balance as of period end
2021-12-31$339.59M-15.7%2023-02-16, Balance as of period end
2020-12-31$402.68M+20.0%2022-02-16, Balance as of period end
2019-12-31$335.63M-13.3%2021-02-11, Balance as of period end
2018-12-31$386.91M-9.3%2020-02-13, Balance as of period end
2017-12-31$426.40M+19.4%2019-02-14, Balance as of period end
2016-12-31$357.25M+23.5%2019-02-14, Balance as of period end
2015-12-31$289.35M+0.3%2018-02-16, Balance as of period end
2014-12-31$288.42M-45.1%2017-02-27, Balance as of period end
2013-12-31$525.15M+64.1%2016-02-18, Balance as of period end
2012-12-31$320.02M+17.2%2015-03-02, Balance as of period end
2011-12-31$272.97M+18.5%2014-03-18, Balance as of period end
2010-12-31$230.34M+45.7%2013-02-27, Balance as of period end
2009-12-31$158.04Mn/c2012-02-28, Balance as of period end
2008-12-31$229.17Mn/a2011-02-23, Balance as of period end

Cash & Equivalents at similar companies

Companies with the same SEC industry code (Wholesale-Drugs, Proprietaries & Druggists' Sundries), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCash & EquivalentsChange YoY
Nu Skin Enterprises, Inc. (NUS)2025-12-31$238.63M+27.7%
Herbalife Ltd. (HLF)2025-12-31$353.10M-15.0%
Cosmos Health Inc. (COSM)2025-12-31$715.7K+127.1%
DataMeds AI, Inc. (MEDS)2025-12-31$42.6K-95.9%
Cardinal Health Inc (CAH)2026-06-30$4.86B+25.3%
Cencora, Inc. (COR)2025-09-30$4.36B+39.1%
McKesson Corp (MCK)2026-03-31$3.98B-30.2%
HWH International Inc. (ESYN)2025-12-31$2.09M-52.0%

Compare NUS, HLF, COSM, MEDS side by side · Screen every company in Wholesale-Drugs, Proprietaries & Druggists' Sundries ↗